NASH ROUNDTABLE

The NASH Roundtable™ was established in 2018 as a platform to stimulate collaboration and dialogue and to build consensus towards validated biomarkers and endpoints and to support the development of effective and safe treatments. Today the Roundtable consists of distinguished physicians, researchers and clinical development experts from three continents brought together by their common commitment to steward advances in science, clinical research and therapeutics for NAFLD and NASH.